WHO Grade 3 Glioma Active Not Recruiting Phase 1 Trials for Selinexor (DB11942)

Also known as: WHO Grade III Gliomas / Grade III Glioma / WHO Grade III Glioma

IndicationStatusPhase
DBCOND0146359 (WHO Grade 3 Glioma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02323880Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasTreatment